Revolution Medicines, Company Insiders
| RVMDW Stock | 0.09 0 3.89% |
Revolution Medicines, employs about 534 people. The company is managed by 10 executives with a total tenure of roughly 1246 years, averaging almost 124.0 years of service per executive, having 53.4 employees per reported executive. Recap of Revolution Medicines,'s management performance can provide insight into the venture performance.
Revolution |
Revolution Medicines, Management Team Effectiveness
The company has return on total asset (ROA) of (0.1866) % which means that it has lost $0.1866 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2933) %, meaning that it generated substantial loss on money invested by shareholders. Revolution Medicines,'s management efficiency ratios could be used to measure how well Revolution Medicines, manages its routine affairs as well as how well it operates its assets and liabilities.Revolution Medicines, Workforce Comparison
Revolution Medicines, Warrant is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 27,928. Revolution Medicines, claims roughly 534 in number of employees contributing just under 2% to equities under Health Care industry.
Revolution Medicines, Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Revolution Medicines, Price Series Summation is a cross summation of Revolution Medicines, price series and its benchmark/peer.
Revolution Medicines, Notable Stakeholders
A Revolution Medicines, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Revolution Medicines, often face trade-offs trying to please all of them. Revolution Medicines,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Revolution Medicines,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mark Goldsmith | President CEO | Profile | |
| Path FRCP | President Development | Profile | |
| Jack Anders | Chief Officer | Profile | |
| Erin Graves | Senior Relations | Profile | |
| Walter Reiher | Chief Officer | Profile | |
| Margaret JD | Chief Officer | Profile | |
| Michael Fischbach | Academic Board | Profile | |
| Xiaolin Wang | Executive Development | Profile | |
| Kevan Shokat | Academic Board | Profile | |
| Jan Smith | Chief Officer | Profile |
About Revolution Medicines, Management Performance
The success or failure of an entity such as Revolution Medicines, often depends on how effective the management is. Revolution Medicines, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Revolution management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Revolution management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Revolution Medicines,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Revolution Medicines, Warrant. Check Revolution Medicines,'s Beneish M Score to see the likelihood of Revolution Medicines,'s management manipulating its earnings.
Revolution Medicines, Workforce Analysis
Traditionally, organizations such as Revolution Medicines, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Revolution Medicines, within its industry.Revolution Medicines, Manpower Efficiency
Return on Revolution Medicines, Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 60M | |
| Working Capital Per Employee | 4.1M | |
| Working Capital Per Executive | 216.4M |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.